Tag: precision oncology market growth

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Precision Oncology Market Revenue Growth On Track For A 10.5% CAGR Through 2030#_x000D_

The precision oncology market has seen substantial growth in recent years. Its value is anticipated to rise from $106.21 billion in 2025 to $117.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. The historical expansion of this market stems from factors including the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, the increasing global prevalence of cancer, the early adoption of immunotherapy, and expanding research in molecular oncology._x000D_

_x000D_

The precision oncology market is projected to experience swift expansion over the coming years. Its valuation is set to reach $175.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This expansion during the forecast timeframe is primarily driven by the advancement of next-generation sequencing platforms, greater incorporation of bioinformatics and AI within oncology, heightened uptake of liquid biopsy and molecular imaging, the broadening of personalized treatment alternatives, and increased research partnerships between medical institutions and pharmaceutical firms. Key trends anticipated for the upcoming period encompass the wider application of targeted cancer therapies derived from molecular profiling, growing acceptance of liquid biopsy and non-invasive diagnostic approaches, an increase in biomarker-guided testing for tailored treatment strategies, the intensifying fusion of immunotherapy with genomic sequencing, and a stronger emphasis on rare and challenging cancer forms._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=99847619&type=smp&name=Precision%20Oncology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Precision Oncology Market Growth Catalysts And Demand Drivers#_x000D_

The rising recognition and adoption of personalized therapies are projected to stimulate the expansion of the precision oncology market moving forward. Personalized therapies involve treatments custom-designed based on an individual’s genetic composition, biomarkers, and distinct disease characteristics to improve effectiveness and lessen adverse effects. The growth in personalized therapies is attributable to breakthroughs in genomic technologies that allow for the precise identification of mutations driving diseases, thereby enabling more efficient and targeted interventions. Precision oncology aids in advancing personalized therapies by employing genomic and molecular profiling to adapt cancer treatment to the specific genetic makeup of a patient’s tumor. For instance, in February 2023, as per GOV.UK, a UK-based government department, the Health and Social Care Secretary entered into an MoU with BioNTech SE to further cancer vaccine research in England, with an objective to deliver 10,000 personalized therapy doses to UK patients by 2030. Consequently, the increasing awareness and shift towards personalized therapies are propelling the growth of the precision oncology market._x000D_

_x000D_

#Precision Oncology Market Segment Landscape And Growth Outlook#_x000D_

The precision oncology market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Genomic Sequencing, Immunotherapy_x000D_

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics_x000D_

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers_x000D_

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy_x000D_

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing_x000D_

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy_x000D_

_x000D_

#Precision Oncology Market Trends Shaping Long-Term Demand#_x000D_

Leading entities within the precision oncology market are concentrating on creating novel methodologies, such as the molecular tumor board, to facilitate customized treatment decisions by integrating genomic information with clinical context. A molecular tumor board constitutes a specialized group of experts who analyze and interpret intricate genomic and molecular test outcomes to guide precision-driven cancer therapies specifically adapted to individual patient tumor characteristics. As an illustration, in December 2024, Aster DM Healthcare Ltd., a healthcare provider based in the UAE, launched a precision oncology clinic, which forms part of three personalized cancer care initiatives aimed at transforming treatment through strategies driven by data and focused on genomics. This particular clinic delivers tailored cancer therapy founded on each patient’s tumor genetic profile, thereby enabling more accurate, impactful treatments with diminished adverse effects. Such an approach enhances treatment efficacy, minimizes harmful side effects, and elevates the quality of life by aligning therapeutic interventions with the distinct molecular attributes of a patient’s cancer._x000D_

_x000D_

#Precision Oncology Market Competitive Landscape: Who Leads The Industry?#_x000D_

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc. _x000D_

_x000D_

#View The Full Precision Oncology Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/precision-oncology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Precision Oncology Market Geographic Analysis: Where Is Demand Rising Fastest?#_x000D_

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Precision Oncology Market Revenue Outlook: What CAGR Is Expected Through 2030?

The precision oncology market has experienced significant expansion in recent years. Projected to rise from $106.21 billion in 2025 to $117.67 billion in 2026, this growth reflects a compound annual growth rate (CAGR) of 10.8%. Historically, this upward trend has been driven by factors such as the restricted access to genomic sequencing tools, a continued dependence on traditional chemotherapy, a worldwide increase in cancer incidence, the early integration of immunotherapy, and advancing investigations into molecular oncology.

Over the coming years, the precision oncology sector is anticipated to expand swiftly, reaching a projected valuation of $175.38 billion by 2030, driven by a compound annual growth rate of 10.5%. This upward trajectory in the forecast period is fueled by the advancement of next-generation sequencing platforms, the growing incorporation of bioinformatics and artificial intelligence into oncology practices, the rising use of liquid biopsy and molecular imaging techniques, the broadening spectrum of personalized therapeutic choices, and an uptick in research partnerships between hospitals and pharmaceutical firms. Key developments shaping the landscape include the broadening of cancer therapies tailored through molecular profiling, a greater reliance on liquid biopsy and minimally invasive diagnostic tools, an upswing in biomarker-driven testing for customized treatment strategies, the increasing fusion of immunotherapy with genomic sequencing, and a heightened emphasis on tackling rare and challenging cancer types.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Precision Oncology Market Growth Drivers: What Factors Are Accelerating Expansion?

The growing recognition and movement toward individualized treatment approaches are anticipated to fuel expansion within the precision oncology sector in the coming period. Customized therapies are designed based on a patient’s genetic profile, biomarkers, and specific disease features in order to maximize therapeutic outcomes while minimizing adverse effects. Their adoption is accelerating largely because of progress in genomic technologies, which now allow for precise identification of mutations responsible for disease progression, enabling more accurate and targeted interventions. By leveraging genomic and molecular profiling, precision oncology plays a key role in advancing these personalized treatments, tailoring cancer care according to the unique genetic characteristics of each patient’s tumor. As an example, in February 2023, the UK government’s Health and Social Care Secretary, as reported by GOV.UK, entered into a memorandum of understanding with BioNTech SE aimed at advancing cancer vaccine research in England, with the goal of making 10,000 personalized therapy doses available to British patients by 2030. Consequently, the increasing focus on and transition toward custom-tailored therapies is driving forward the growth of the precision oncology market.

Precision Oncology Market Segment Performance And Strategic Opportunities

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Precision Oncology Market Trends: What Is Shaping Future Industry Growth?

Leading players within the precision oncology sector are actively pursuing novel strategies, including the implementation of molecular tumor boards, to facilitate individualized treatment choices that merge genomic data with clinical considerations. A molecular tumor board is defined as a specialized panel of professionals tasked with reviewing and deciphering intricate genomic and molecular testing results, thereby guiding targeted cancer treatments that address the distinct tumor traits of each patient. For example, in December 2024, Aster DM Healthcare Ltd., a healthcare organization headquartered in the UAE, launched a precision oncology clinic as part of three personalized cancer care programs aimed at revolutionizing therapy through data- and genomics-based methods. This facility provides tailored cancer treatments derived from the genetic profile of an individual’s tumor, allowing for more accurate and effective interventions while lowering adverse effects. The strategy boosts therapeutic results, lessens toxicity, and elevates quality of life by matching therapies with the distinct molecular characteristics of a patient’s cancer.

Precision Oncology Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Precision Oncology Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Precision Oncology Market Projected To Expand During 2026–2030?

The precision oncology market has seen rapid expansion in recent years. Its valuation is expected to climb from $106.21 billion in 2025 to $117.67 billion in 2026, indicating a compound annual growth rate (CAGR) of 10.8%. The historical growth of this market can be attributed to the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, increasing cancer prevalence globally, the early adoption of immunotherapy, and burgeoning research in molecular oncology.

The precision oncology market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $175.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. The expansion during the forecast period can be attributed to the advancement of next-generation sequencing platforms, the increasing integration of bioinformatics and artificial intelligence in oncology, the rising adoption of liquid biopsy and molecular imaging, the broadening of personalized treatment alternatives, and the growth of research partnerships between hospitals and pharmaceutical enterprises. Significant trends in the forecast period include the broadening of targeted cancer therapies based on molecular profiling, the increasing embrace of liquid biopsy and non-invasive diagnostic methodologies, an increase in biomarker-based testing for individualized treatment plans, the escalating integration of immunotherapy with genomic sequencing, and a heightened focus on rare and difficult-to-treat cancer varieties.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

Which Drivers Are Advancing The Precision Oncology Market Growth?

The growing understanding and transition towards tailored treatments are projected to fuel the expansion of the precision oncology market moving forward. Tailored treatments are therapeutic approaches customized to an individual’s genetic makeup, biological markers, and specific disease characteristics, designed to enhance efficacy and mitigate side effects. The rise in personalized therapies stems from breakthroughs in genomic technologies, which facilitate the precise identification of disease-causing mutations, enabling more potent and focused interventions. Precision oncology advances personalized therapies through the application of genomic and molecular profiling to customize cancer treatment according to the specific genetic composition of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a government department based in the UK, announced that the Health and Social Care Secretary signed a Memorandum of Understanding with BioNTech SE to accelerate cancer vaccine research in England, with a goal of delivering 10,000 personalized therapy doses to UK patients by 2030. Hence, the increasing awareness and adoption of personalized therapies are driving the growth of the precision oncology market.

How Is The Precision Oncology Market Examined Through Segment Analysis?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Which Trends Are Guiding The Development Of The Precision Oncology Market?

Companies operating in the precision oncology market are prioritizing the development of innovative strategies, such as the molecular tumor board, to support personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board represents a dedicated group of specialists who analyze and interpret complex genomic and molecular test data to guide precision-driven cancer therapies, specifically tailored to the unique tumor characteristics of individual patients. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic as one of three personalized cancer care initiatives designed to transform treatment through data-driven, genomic-focused strategies. This clinic delivers customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise, effective treatments with reduced side effects. This approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by aligning therapies with the unique molecular features of a patient’s cancer.

Which Key Players Are Active In The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Geographic Region Represents The Largest Precision Oncology Market Share?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Precision Oncology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Precision Oncology Market Expected To Change From 2026 To 2030?

The precision oncology market has experienced significant expansion in recent years. It is projected to expand from $106.21 billion in 2025 to $117.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. Factors contributing to its historical growth include the scarcity of genomic sequencing technologies, the dependence on traditional chemotherapy, a global rise in cancer cases, the early embrace of immunotherapy, and increasing research activities in molecular oncology.

The precision oncology market is poised for significant expansion in the coming years, projected to reach $175.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This anticipated growth is driven by factors such as the advancement of next-generation sequencing platforms, the growing integration of bioinformatics and artificial intelligence within oncology, the increasing embrace of liquid biopsy and molecular imaging techniques, the broadening availability of personalized treatment choices, and enhanced research partnerships between medical institutions and pharmaceutical firms. Key trends anticipated during this period encompass the wider application of targeted cancer therapies informed by molecular profiling, the continued rise in the use of liquid biopsy and other non-invasive diagnostic approaches, the expansion of biomarker-based testing for tailored treatment strategies, the increasing merger of immunotherapy with genomic sequencing, and a heightened concentration on rare and challenging-to-treat cancer varieties.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Significant Factors Are Influencing The Precision Oncology Market Expansion?

A growing understanding and move towards tailored medical treatments are anticipated to fuel the expansion of the precision oncology market in the future. These therapies involve treatments uniquely designed for an individual’s genetic profile, biological markers, and distinct disease traits, with the goal of improving efficacy and minimizing adverse reactions. The rise of personalized therapies is attributed to progress in genomic technologies, which facilitate the accurate detection of mutations that drive diseases, thereby enabling more potent and focused interventions. Precision oncology plays a crucial role in advancing personalized therapies through the application of genomic and molecular profiling, which customizes cancer treatment according to the unique genetic composition of a patient’s tumor. As an illustration, in February 2023, as reported by GOV.UK, a UK-based government department, the Health and Social Care Secretary entered into a Memorandum of Understanding with BioNTech SE. This agreement seeks to further cancer vaccine research in England, with an objective to provide 10,000 personalized therapy doses to UK patients by 2030. Consequently, the heightened awareness and transition towards personalized therapies are fueling the expansion of the precision oncology market.

Which Segment Types Are Examined In The Precision Oncology Market Segment Study?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Market Trends Are Affecting The Precision Oncology Market?

Leading companies operating in the precision oncology market are concentrating on developing innovative strategies, such as the molecular tumor board, to support personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board typically refers to a dedicated panel of specialists tasked with analyzing and interpreting complex genomic and molecular test data, thereby informing precision-driven cancer therapies that are specifically tailored to the unique tumor characteristics of individual patients. An example of this occurred in December 2024, when Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic. This was part of three personalized cancer care initiatives aimed at transforming treatment through data-driven, genomic-focused strategies. This clinic provides customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise and effective treatments while reducing side effects. Such an approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by carefully aligning therapies with the distinct molecular features of a patient’s cancer.

Which Players Are Part Of The Competitive Landscape Of The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Get The Full Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Region Represents The Largest Share Of The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Precision Oncology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Precision Oncology Market Evolve From 2026 To 2030?

The precision oncology market has witnessed rapid expansion in recent years. It is anticipated to increase from $106.21 billion in 2025 to $117.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.8%. The historical growth can be linked to the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, a globally increasing cancer prevalence, the early adoption of immunotherapy, and expanding research in molecular oncology.

The precision oncology market is set for substantial growth over the next few years, with projections indicating it will expand to $175.38 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.5%. This anticipated expansion is attributed to several factors, including the ongoing development of next-generation sequencing platforms, the increasing integration of bioinformatics and artificial intelligence into oncology practices, a rising adoption of liquid biopsy and molecular imaging techniques, the continuous expansion of personalized treatment options, and the growth of collaborative research efforts between hospitals and pharmaceutical companies. Major trends identified for the forecast period include the broader availability of targeted cancer therapies based on molecular profiling, a growing embrace of liquid biopsy and other non-invasive diagnostic methods, an increase in biomarker-based testing to inform personalized treatment plans, the rising incorporation of immunotherapy alongside genomic sequencing, and an enhanced focus on tackling rare and difficult-to-treat cancer types.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Key Drivers Are Influencing The Growth Of The Precision Oncology Market?

A heightened understanding and growing adoption of personalized therapies are projected to stimulate the growth of the precision oncology market moving forward. Personalized therapies are medical interventions specifically designed based on an individual’s genetic makeup, biomarkers, and particular disease characteristics, intending to boost effectiveness and lessen side effects. The expansion of these therapies is attributed to breakthroughs in genomic technologies, which allow for the accurate detection of disease-causing mutations, thereby enabling more potent and precise treatments. Precision oncology contributes to the progress of personalized therapies through the use of genomic and molecular profiling to customize cancer treatment according to the unique genetic profile of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a UK-based government department, reported that the Health and Social Care Secretary signed a Memorandum of Understanding with BioNTech SE to further cancer vaccine research in England, with the goal of providing 10,000 personalized therapy doses to UK patients by 2030. Thus, the increasing awareness and transition towards personalized therapies are indeed propelling the expansion of the precision oncology market.

Which Segment Areas Are Covered In The Precision Oncology Market Analysis?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Key Developments And Trends Are Impacting The Precision Oncology Market?

Leading firms within the precision oncology market are concentrating on creating novel methodologies, like the molecular tumor board, to facilitate personalized treatment choices through the integration of genomic data with clinical backgrounds. This board comprises a specialized group of experts who examine and decode intricate genomic and molecular test results to guide precision-focused cancer treatments customized to a patient’s unique tumor features. As an illustration, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as one of three personalized cancer care programs aimed at revolutionizing treatment via data-driven, genomic-centric strategies. The clinic offers tailored cancer therapy derived from each patient’s tumor genetic profile, allowing for more accurate and effective treatments while minimizing adverse reactions. This methodology improves treatment results, lessens toxicity, and elevates quality of life by aligning therapies with the distinctive molecular attributes of a patient’s cancer.

Which Global Companies Are Actively Competing In The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Read the full precision oncology market report here:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Precision Oncology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Precision Oncology Market Evolve From 2026 To 2030?

The precision oncology market has witnessed rapid expansion in recent years. It is anticipated to increase from $106.21 billion in 2025 to $117.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.8%. The historical growth can be linked to the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, a globally increasing cancer prevalence, the early adoption of immunotherapy, and expanding research in molecular oncology.

The precision oncology market is set for substantial growth over the next few years, with projections indicating it will expand to $175.38 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.5%. This anticipated expansion is attributed to several factors, including the ongoing development of next-generation sequencing platforms, the increasing integration of bioinformatics and artificial intelligence into oncology practices, a rising adoption of liquid biopsy and molecular imaging techniques, the continuous expansion of personalized treatment options, and the growth of collaborative research efforts between hospitals and pharmaceutical companies. Major trends identified for the forecast period include the broader availability of targeted cancer therapies based on molecular profiling, a growing embrace of liquid biopsy and other non-invasive diagnostic methods, an increase in biomarker-based testing to inform personalized treatment plans, the rising incorporation of immunotherapy alongside genomic sequencing, and an enhanced focus on tackling rare and difficult-to-treat cancer types.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Key Drivers Are Influencing The Growth Of The Precision Oncology Market?

A heightened understanding and growing adoption of personalized therapies are projected to stimulate the growth of the precision oncology market moving forward. Personalized therapies are medical interventions specifically designed based on an individual’s genetic makeup, biomarkers, and particular disease characteristics, intending to boost effectiveness and lessen side effects. The expansion of these therapies is attributed to breakthroughs in genomic technologies, which allow for the accurate detection of disease-causing mutations, thereby enabling more potent and precise treatments. Precision oncology contributes to the progress of personalized therapies through the use of genomic and molecular profiling to customize cancer treatment according to the unique genetic profile of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a UK-based government department, reported that the Health and Social Care Secretary signed a Memorandum of Understanding with BioNTech SE to further cancer vaccine research in England, with the goal of providing 10,000 personalized therapy doses to UK patients by 2030. Thus, the increasing awareness and transition towards personalized therapies are indeed propelling the expansion of the precision oncology market.

Which Segment Areas Are Covered In The Precision Oncology Market Analysis?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Key Developments And Trends Are Impacting The Precision Oncology Market?

Leading firms within the precision oncology market are concentrating on creating novel methodologies, like the molecular tumor board, to facilitate personalized treatment choices through the integration of genomic data with clinical backgrounds. This board comprises a specialized group of experts who examine and decode intricate genomic and molecular test results to guide precision-focused cancer treatments customized to a patient’s unique tumor features. As an illustration, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as one of three personalized cancer care programs aimed at revolutionizing treatment via data-driven, genomic-centric strategies. The clinic offers tailored cancer therapy derived from each patient’s tumor genetic profile, allowing for more accurate and effective treatments while minimizing adverse reactions. This methodology improves treatment results, lessens toxicity, and elevates quality of life by aligning therapies with the distinctive molecular attributes of a patient’s cancer.

Which Global Companies Are Actively Competing In The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Read the full precision oncology market report here:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Precision Oncology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Precision Oncology Market Evolve From 2026 To 2030?

The precision oncology market has witnessed rapid expansion in recent years. It is anticipated to increase from $106.21 billion in 2025 to $117.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.8%. The historical growth can be linked to the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, a globally increasing cancer prevalence, the early adoption of immunotherapy, and expanding research in molecular oncology.

The precision oncology market is set for substantial growth over the next few years, with projections indicating it will expand to $175.38 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.5%. This anticipated expansion is attributed to several factors, including the ongoing development of next-generation sequencing platforms, the increasing integration of bioinformatics and artificial intelligence into oncology practices, a rising adoption of liquid biopsy and molecular imaging techniques, the continuous expansion of personalized treatment options, and the growth of collaborative research efforts between hospitals and pharmaceutical companies. Major trends identified for the forecast period include the broader availability of targeted cancer therapies based on molecular profiling, a growing embrace of liquid biopsy and other non-invasive diagnostic methods, an increase in biomarker-based testing to inform personalized treatment plans, the rising incorporation of immunotherapy alongside genomic sequencing, and an enhanced focus on tackling rare and difficult-to-treat cancer types.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Key Drivers Are Influencing The Growth Of The Precision Oncology Market?

A heightened understanding and growing adoption of personalized therapies are projected to stimulate the growth of the precision oncology market moving forward. Personalized therapies are medical interventions specifically designed based on an individual’s genetic makeup, biomarkers, and particular disease characteristics, intending to boost effectiveness and lessen side effects. The expansion of these therapies is attributed to breakthroughs in genomic technologies, which allow for the accurate detection of disease-causing mutations, thereby enabling more potent and precise treatments. Precision oncology contributes to the progress of personalized therapies through the use of genomic and molecular profiling to customize cancer treatment according to the unique genetic profile of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a UK-based government department, reported that the Health and Social Care Secretary signed a Memorandum of Understanding with BioNTech SE to further cancer vaccine research in England, with the goal of providing 10,000 personalized therapy doses to UK patients by 2030. Thus, the increasing awareness and transition towards personalized therapies are indeed propelling the expansion of the precision oncology market.

Which Segment Areas Are Covered In The Precision Oncology Market Analysis?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Key Developments And Trends Are Impacting The Precision Oncology Market?

Leading firms within the precision oncology market are concentrating on creating novel methodologies, like the molecular tumor board, to facilitate personalized treatment choices through the integration of genomic data with clinical backgrounds. This board comprises a specialized group of experts who examine and decode intricate genomic and molecular test results to guide precision-focused cancer treatments customized to a patient’s unique tumor features. As an illustration, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as one of three personalized cancer care programs aimed at revolutionizing treatment via data-driven, genomic-centric strategies. The clinic offers tailored cancer therapy derived from each patient’s tumor genetic profile, allowing for more accurate and effective treatments while minimizing adverse reactions. This methodology improves treatment results, lessens toxicity, and elevates quality of life by aligning therapies with the distinctive molecular attributes of a patient’s cancer.

Which Global Companies Are Actively Competing In The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Read the full precision oncology market report here:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Precision Oncology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the precision oncology market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Precision Oncology Market show for the 2026–2030 period?

The precision oncology market has witnessed rapid growth in recent years. It is projected to increase from $106.21 billion in 2025 to $117.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to several factors, including the constrained availability of genomic sequencing technologies, the reliance on conventional chemotherapy, the rising global prevalence of cancer, the early embrace of immunotherapy, and the expanding research in molecular oncology.

The precision oncology market is poised for significant expansion in the coming years, projected to reach $175.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. Key drivers for this anticipated growth include the advancement of next-generation sequencing platforms, greater integration of bioinformatics and artificial intelligence (AI) in oncology, increased uptake of liquid biopsy and molecular imaging, the broadening of personalized treatment alternatives, and enhanced research partnerships between medical institutions and pharmaceutical firms. Prominent trends during this forecast period encompass the proliferation of targeted cancer therapies informed by molecular profiling, the wider acceptance of liquid biopsy and non-invasive diagnostic approaches, an increase in biomarker-based testing for tailored treatment strategies, the growing convergence of immunotherapy with genomic sequencing, and a heightened emphasis on addressing rare and challenging cancer types.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Drivers Are Shaping The Development Of The Precision Oncology Market?

The increasing awareness and shift towards personalized therapies are expected to propel the growth of the precision oncology market going forward. These personalized therapies are treatments customized to an individual’s genetic makeup, biomarkers, and specific disease characteristics to enhance effectiveness and reduce side effects. The increasing adoption of personalized therapies is due to advancements in genomic technologies that enable the precise identification of disease-driving mutations, allowing for more effective and targeted treatments. Precision oncology helps advance personalized therapies by using genomic and molecular profiling to tailor cancer treatment to the specific genetic makeup of a patient’s tumor. For instance, in February 2023, according to GOV.UK, a UK-based government department, the Health and Social Care Secretary signed an MoU with BioNTech SE to advance cancer vaccine research in England, aiming to deliver 10,000 personalized therapy doses to UK patients by 2030. Therefore, the increasing awareness and shift towards personalized therapies are driving the growth of the precision oncology market.

Which Segments Are Contributing To The Growth Of The Precision Oncology Market?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Which Trends Are Expected To Influence The Precision Oncology Market In The Upcoming Years?

Leading companies within the precision oncology market are concentrating on developing novel approaches, such as the molecular tumor board, to facilitate personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board refers to a specialized group of experts that examines and interprets complex genomic and molecular test data to guide precision-driven cancer therapies tailored to the specific tumor characteristics of individual patients. For example, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic as one of three personalized cancer care initiatives intended to revolutionize treatment through data-driven, genomic-focused strategies. This clinic provides customized cancer therapy based on each patient’s tumor genetic profile, enabling more accurate, effective treatments with fewer adverse effects. The method improves treatment outcomes, reduces toxicity, and enhances quality of life by aligning therapies with the unique molecular features of a patient’s cancer.

Who Are The Prominent Global Companies Shaping The Precision Oncology Market Landscape?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Precision Oncology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the precision oncology market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Growth Outlook For The Precision Oncology Market?

The precision oncology market has experienced significant growth in recent years. Projections indicate it will expand from $95.73 billion in 2024 to reach $106.21 billion by 2025, driven by a compound annual growth rate (CAGR) of 11.0%. This historical expansion can be attributed to several factors, including an increasing number of companion diagnostics approvals, a heightened focus on biomarker discovery and validation, growing investments in oncology research and innovation, a rise in precision oncology clinical trials, and an increasing preference for minimally invasive diagnostic techniques.

The precision oncology market is poised for significant expansion over the next few years, with its value forecast to reach $158.90 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This expected growth during the forecast period stems from factors such as the increasing prevalence of cancer, the rising adoption of genomics-based diagnostic tools, greater awareness among patients and clinicians, the expanding utilization of next-generation sequencing, and a growing demand for targeted cancer therapies. Prominent trends anticipated in the forecast period include advancements in liquid biopsy technologies, the sophisticated application of single-cell sequencing in tumor analysis, the development of decentralized testing platforms, innovations in radiogenomics for treatment planning, and progress in patient-specific cancer vaccines.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Core Drivers Are Expected To Influence The Precision Oncology Market?

The future expansion of the precision oncology market is anticipated to be fueled by growing recognition and a move towards personalized therapeutic approaches. Personalized therapies are defined as treatments specifically tailored to an individual’s genetic composition, biological markers, and distinct disease attributes, aiming to boost efficacy and minimize adverse reactions. The proliferation of these therapies is attributed to breakthroughs in genomic technologies, which facilitate the accurate detection of disease-causing mutations, enabling more potent and targeted interventions. Precision oncology significantly contributes to the advancement of personalized therapies through the application of genomic and molecular profiling, which customizes cancer treatment to align with the unique genetic profile of a patient’s tumor. An illustrative example occurred in February 2023, when the Health and Social Care Secretary, per GOV.UK, a UK-based government department, entered into a Memorandum of Understanding with BioNTech SE to further cancer vaccine research in England, with an objective to provide 10,000 personalized therapy doses to UK patients by 2030. Consequently, the rising awareness and adoption of personalized therapies are indeed propelling the growth of the precision oncology market.

Which Segmentation Categories Are Highlighted In The Precision Oncology Market Analysis?

The precision oncology market covered in this report is segmented

1) By Type: Genomic Sequencing, Immunotherapy

2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Which Market Trends Are Expected To Define The Future Of The Precision Oncology Market?

Leading firms within the precision oncology sector are concentrating on creating novel methodologies, like the molecular tumor board, to facilitate individualized treatment choices through the combination of genomic data and clinical understanding. A molecular tumor board is defined as a specialized group of experts who examine and decode intricate genomic and molecular test results to guide precise cancer treatments customized to each patient’s unique tumor traits. As an example, in December 2024, Aster DM Healthcare Ltd., a healthcare provider based in the UAE, launched a precision oncology clinic. This was one of three personalized cancer care programs aimed at revolutionizing treatment via data-driven, genomics-centered approaches. This clinic provides bespoke cancer therapy founded on the genetic profile of each patient’s tumor, leading to more accurate and potent treatments with fewer adverse effects. This methodology improves treatment results, lessens toxicity, and enhances quality of life by matching therapies to the distinct molecular attributes of a patient’s cancer.

Who Are The Dominant Players In The Precision Oncology Market Today?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2025, By The Business Research Company

Precast Concrete Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Drill Pipe Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Pipeline Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pipeline-construction-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Precision Oncology Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The precision oncology market has seen rapid expansion in recent years. It is forecast to increase from $95.73 billion in 2024 to $106.21 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.0%. This market’s historical growth can be attributed to an increasing number of companion diagnostics receiving approval, a heightened focus on biomarker discovery and validation, rising investments in oncology research and innovation, an expansion in precision oncology clinical trials, and a growing preference for minimally invasive diagnostic techniques.

The precision oncology market is poised for significant expansion over the coming years. Its valuation is projected to reach $158.90 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period stems from factors such as the increasing incidence of cancer, the growing acceptance of genomics-based diagnostic tools, heightened awareness among both patients and medical professionals, the expanded use of next-generation sequencing, and the escalating need for targeted cancer treatments. Key trends anticipated for the forecast period encompass advancements in liquid biopsy technologies, the sophisticated application of single-cell sequencing for tumor examination, the creation of decentralized testing platforms, pioneering work in radiogenomics for treatment strategy, and progress in developing patient-specific cancer vaccines.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Are The Top Growth Drivers Impacting The Precision Oncology Market Outlook?

Growing recognition and a move towards personalized treatments are anticipated to fuel the expansion of the precision oncology market in the future. These therapies are tailored medical interventions, crafted based on a person’s unique genetic profile, biological markers, and particular disease features, with the aim of boosting efficacy and minimizing adverse reactions. The rise of personalized therapies is attributed to progress in genomic technologies, which facilitate the accurate detection of mutations that drive diseases, leading to more potent and focused therapeutic approaches. Precision oncology contributes to the advancement of personalized therapies by employing genomic and molecular profiling to customize cancer treatments according to the unique genetic composition of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a government department based in the UK, reported that the Health and Social Care Secretary had signed a Memorandum of Understanding with BioNTech SE. This agreement aims to further cancer vaccine research in England, with a target of providing 10,000 personalized therapy doses to UK patients by 2030. Consequently, the growing recognition and adoption of personalized therapies are propelling the expansion of the precision oncology market.

What Are The Major Segment Types Covered In The Precision Oncology Market?

The precision oncology market covered in this report is segmented

1) By Type: Genomic Sequencing, Immunotherapy

2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Trends Are Redefining The Precision Oncology Market Dynamics?

Leading companies operating in the precision oncology market are concentrating on developing novel approaches, such as the molecular tumor board, to support individualized treatment decisions by integrating genomic information with clinical context. A molecular tumor board is a dedicated panel of specialists that analyzes and interprets complex genomic and molecular test data to guide precision-driven cancer therapies tailored to the specific tumor characteristics of individual patients. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as part of three personalized cancer care initiatives designed to transform treatment through data-driven, genomic-focused strategies. This clinic delivers customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise, effective treatments with reduced side effects. This approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by aligning therapies to the unique molecular features of a patient’s cancer.

Which Leading Companies Dominate The Precision Oncology Market Share?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Regional Markets Are Contributing Most To The Precision Oncology Industry Expansion?

North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2025, By The Business Research Company

Precast Concrete Market 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model